New Onset Refractory Status Epilepticus (NORSE)

Go Back to All Clinical Trials

New Onset Refractory Status Epilepticus (NORSE)

Brief description of study

The purpose of this study is to establish a research bank of data and biospecimens for future research on new onset refractory status epilepticus (NORSE). Status epilepticus is when seizures occur one after another without stopping. The term “refractory” is used to describe your condition because your status epilepticus did not get any better with medicine, making it hard to treat. In this case, the condition is called “new onset refractory status epilepticus” (NORSE). The tissue samples, biological specimen(s) and data collected in this bank will be used by researchers to help understand the cause of new-onset refractory status epilepticus (NORSE), to identify the key determinants of outcome and to determine the best management strategy to treat patients that present with new-onset refractory status epilepticus.

Clinical Study Identifier: s18-01938

Principal Investigator: Claude Steriade.

Other Investigator: Amy C. Jongeling.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies